TickerFacts.

Gain Therapeutics, Inc. (GANX): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

-$18.90M
Year ended 2024-12-31
2020-12-31: -$3.26M2021-12-31: -$12.46M2022-12-31: -$14.81M2023-12-31: -$18.88M2024-12-31: -$18.90M-$18.90M
2020-12-31 Free Cash Flow (USD) 2024-12-31
Period endedFree Cash FlowChange YoYSource filing
2024-12-31-$18.90Mn/m2026-03-26, From 2024-01-01
2023-12-31-$18.88Mn/m2025-03-27, From 2023-01-01
2022-12-31-$14.81Mn/m2024-03-26, From 2022-01-01
2021-12-31-$12.46Mn/m2023-03-23, From 2021-01-01
2020-12-31-$3.26Mn/a2022-03-25, From 2020-01-01